vancomycin has been researched along with losartan potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslan, C; Cetin, H; Ciris, M; Oktem, F; Olgar, S; Ozguner, F; Uz, E | 1 |
| Beck, W; Boschetti-de-Fierro, A; Gebert, M; Haug, U; Hulko, M; Krause, B; Storr, M; Voigt, M | 1 |
2 other study(ies) available for vancomycin and losartan potassium
| Article | Year |
|---|---|
Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Blood Urea Nitrogen; Catalase; Creatinine; Disease Models, Animal; Epoetin Alfa; Erythropoietin; Kidney; Kidney Diseases; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Recombinant Proteins; Superoxide Dismutase; Vancomycin | 2007 |
Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration.
Topics: Blood Coagulation Factors; Erythropoietin; Hemodiafiltration; Heparin; Humans; Insulin; Molecular Weight; Vancomycin | 2019 |